Teva CEO on Advancing Health Care | BCG
Teva CEO Richard Francis on Q2 earnings beat
Months after joining, Teva CEO pulls curtain back on strategy to return to growth
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Teva has made short work of its hunt for a new CEO
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva CEO sees no value now in separating brands, generics businesses | Seeking Alpha
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised -August 02, 2023 at 03:19 pm EDT | MarketScreener
Tel Aviv-based Teva CEO: Our manufacturing is unaffected as it stands
Kare Schultz | C-SPAN.org
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva CEO exits amid crisis of confidence at drugmaker
Erez Vigodman steps down as Teva CEO
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Where is Kåre Schultz? | Ctech
Five Things Facing Teva's New CEO Richard Francis :: Generics Bulletin
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva Pharmaceuticals on X: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
